Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Similarity Study of LY06006 Versus US Prolia and EU Prolia in Healthy Male Subjects
NCT06095427Phase 1Completed
- Sponsor
- Boan Biotech
- Start
- Mar 2021
- Primary completion
- Mar 2023
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of CMAB807 in osteoporosis (3 arms), sponsored by Boan Biotech. Primary endpoints: Area under the concentration-time curve from time zero to the last quantifiable concentration, Maximum observed concentration and 1 more. Started Mar 2021; status: completed.
02
Drugs
CMAB807
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT06095427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06095427.